Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows From Operating Activities:
Net loss	$ (49,431)	$ (40,360)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	41,276	41,408
Amortization of debt issuance costs and discounts	2,701	4,240
Loss on sale or disposal of assets	908	4,147
Deferred income tax provision	(32,772)	(24,046)
Equity-based compensation	762	320
Changes in assets and liabilities:
Accounts receivable	3,231	(2,240)
Inventories	(5,579)	(5,897)
Prepaid expenses and other current assets	(3,417)	(6,125)
Accounts payable	10,636	11,095
Accrued salaries, wages and benefits	(7,532)	(16,017)
Deferred revenue	41,293	44,766
Other accrued expenses	10,034	12,306
Other assets and liabilities	901	577
Net cash provided by operating activities	13,011	24,174
Cash Flows From Investing Activities:
Capital expenditures	(46,827)	(32,319)
Change in restricted cash	(504)	(467)
Net cash used in investing activities	(47,331)	(32,786)
Cash Flows From Financing Activities:
Repayment of long-term debt	(3,512)	(5,229)
Proceeds from draw on revolving credit facility		35,000
Repayment of revolving credit facility		(5,000)
Dividends paid to stockholders	(17,691)	(184)
Payment of tax withholdings on equity-based compensation through shares withheld	(78)
Offering costs		(2,283)
Net cash (used in) provided by financing activities	(21,281)	22,304
Change in Cash and Cash Equivalents	(55,601)	13,692
Cash and Cash Equivalents-Beginning of period	116,841	45,675
Cash and Cash Equivalents-End of period	61,240	59,367
Supplemental Disclosures of Noncash Investing and Financing Activities
Capital expenditures in accounts payable	31,506	34,548
Dividends declared, but unpaid	$ 18,015